Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome

Phase 4 Completed 100 enrolled Aichi Gakuin University

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate anti-oxidative and anti-inflammatory effects of pitavastatin in hypercholesterolemic patients with the metabolic syndrome.

Timeline

Start: 2007-04
Primary completion: 2008-09
Completion: 2008-09

Publications

Matsubara T, Naruse K, Arakawa T, Nakao M, Yokoi K, Oguri M, Marui N, Amano T, Ichimiya S, Ohashi T, Imai K, Sakai S, Sugiyama S, Ishii H, Murohara T. Impact of pitavastatin on high-sensitivity C-reactive protein and adiponectin in hypercholesterolemic patients with the metabolic syndrome: the PREMIUM Study. J Cardiol. 2012 Nov;60(5):389-94. doi: 10.1016/j.jjcc.2012.07.012. Epub 2012 Aug 11.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pitavastatin	Small molecule	2 mg	—

Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome

Summary

Timeline

Publications

Drugs

Indications